Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aldosterone and spironolactone in heart failure.

× No keyword cloud information.

12 in total

1. Accelerated publication versus usual publication in 2 leading medical journals.

Authors: William A Ghali; Jacques Cornuz; Finlay A McAlister; Jean-Blaise Wasserfallen; P J Devereaux; C David Naylor
Journal: CMAJ Date: 2002-04-30 Impact factor: 8.262

Review 2. Heart failure and shock complicating acute coronary syndromes.

Authors: Frederick A Spencer; Theo Meyer
Journal: Curr Cardiol Rep Date: 2005-07 Impact factor: 2.931

3. Mineralocorticoid-receptor antagonists in heart failure: a tale of serendipity and success.

Authors: Alex Reyentovich; Stuart D Katz
Journal: Curr Heart Fail Rep Date: 2011-06

4. Eplerenone, an aldosterone antagonist, reduces hospitalization and death in heart failure patients with NYHA class II and an ejection fraction of less than 30%.

Authors: Simone Birocchi; Giulia Carla Luisa Cernuschi
Journal: Intern Emerg Med Date: 2011-07-17 Impact factor: 3.397

5. Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience.

Authors: Grace K Kim; James Q Del Rosso
Journal: J Clin Aesthet Dermatol Date: 2012-03

Review 6. Pharmacological management of chronic heart failure in adults: a review of the literature.

Authors: Richard Auty
Journal: Malawi Med J Date: 2004-03 Impact factor: 0.875

Review 7. Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experience.

Authors: Ward A Heggermont; Marc Goethals; Riet Dierckx; Sofie Verstreken; Jozef Bartunek; Marc Vanderheyden
Journal: Heart Fail Rev Date: 2016-11 Impact factor: 4.214

8. Treatment with spironolactone for 24 weeks decreases the level of matrix metalloproteinases and improves cardiac function in patients with chronic heart failure of ischemic etiology.

Authors: M J Li; C X Huang; E Okello; T Yanhong; S Mohamed
Journal: Can J Cardiol Date: 2009-09 Impact factor: 5.223

9. Aldosterone Receptor Blockers in the Treatment of Heart Failure.

Authors: Anita Deswal; David Yao
Journal: Curr Treat Options Cardiovasc Med Date: 2004-08

Review 10. Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure.

Authors: Giuseppe Distefano; Pietro Sciacca
Journal: Ital J Pediatr Date: 2012-09-12 Impact factor: 2.638